Status:
COMPLETED
Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation
Lead Sponsor:
Emory University
Conditions:
Atrial Fibrillation
Inflammation
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation is an abnormal heart beat that starts in the upper parts of the heart and can cause stroke or death, if untreated. In general, treatments are not very effective, with frequent rela...
Detailed Description
Atrial fibrillation is an abnormal heart beat that starts in the upper parts of the heart and can cause stroke or death, if untreated. In general, treatments are not very effective with frequent relap...
Eligibility Criteria
Inclusion
- Cases must have atrial fibrillation documented on electrocardiographic recordings at the time of enrollment.
Exclusion
- Atrial fibrillation
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT00142194
Start Date
June 1 2005
End Date
November 1 2007
Last Update
September 27 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital
Atlanta, Georgia, United States, 30322
2
Crawford Long Hospital
Atlanta, Georgia, United States, 30365